Effect of Bimonthly Supplementation With Oral Cholecalciferol on Serum 25-Hydroxyvitamin D Concentrations in HIV-Infected Children and Adolescents
العنوان: | Effect of Bimonthly Supplementation With Oral Cholecalciferol on Serum 25-Hydroxyvitamin D Concentrations in HIV-Infected Children and Adolescents |
---|---|
المؤلفون: | Elizabeth Shane, Donald J. McMahon, Ellen S. Engelson, Elaine J. Abrams, Mary Horlick, Marukh Bamji, Stephen M. Arpadi, Murli Purswani |
المصدر: | Pediatrics. 123:e121-e126 |
بيانات النشر: | American Academy of Pediatrics (AAP), 2009. |
سنة النشر: | 2009 |
مصطلحات موضوعية: | Male, medicine.medical_specialty, Adolescent, Administration, Oral, Physiology, chemistry.chemical_element, HIV Infections, Calcium, Placebo, Article, Drug Administration Schedule, chemistry.chemical_compound, Internal medicine, medicine, Vitamin D and neurology, Humans, Hypercalciuria, Vitamin D, Child, Cholecalciferol, business.industry, Area under the curve, Radioimmunoassay, medicine.disease, Endocrinology, chemistry, Dietary Supplements, Pediatrics, Perinatology and Child Health, Female, business, Viral load |
الوصف: | OBJECTIVE. Vitamin D insufficiency occurs commonly in HIV-infected youth in the United States. In light of the importance of vitamin D for skeletal and nonskeletal health, including innate immunity, developing methods for improving vitamin D status in HIV-infected children and adolescents is an important area of clinical research. The objective of this study was to evaluate the effect of administration of oral cholecalciferol, 100000 IU every 2 months, and 1 g/day calcium on serum 25-hydroxyvitamin D concentrations, serum and urine calcium, and HIV disease progression during a 12-month period. METHODS. HIV-infected children and adolescents who were aged 6 to 16 years were randomly assigned to receive vitamin D (100000 IU bimonthly) and calcium (1 g/day; n = 29) or double placebo (n = 27). Serum 25-hydroxyvitamin D concentrations as measured by radioimmunoassay, albumin-corrected calcium concentrations, and spot urinary calcium-creatinine ratios were determined monthly. RESULTS. No abnormalities in serum calcium concentration were observed. One participant who received placebo developed hypercalciuria. No group differences were seen in the change in CD4 count or CD4% or viral load during 12 months. The overall mean monthly serum 25-hydroxyvitamin D concentrations were higher in the group that received vitamin D and calcium than in the placebo group, as was the monthly serum 25-hydroxyvitamin D area under the curve. After completing 12 months of study, 2 (6.7%) participants in the group that received vitamin D and calcium had a trough serum 25-hydroxyvitamin D concentration CONCLUSIONS. Administration of oral cholecalciferol to HIV-infected children and adolescents at a dosage of 100000 IU every 2 months, together with 1 g/day calcium, is safe and results in significant increases in serum 25-hydroxyvitamin D concentrations. |
تدمد: | 1098-4275 0031-4005 |
الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e8ba1cb9422d7974016707ab88b8decTest https://doi.org/10.1542/peds.2008-0176Test |
حقوق: | OPEN |
رقم الانضمام: | edsair.doi.dedup.....2e8ba1cb9422d7974016707ab88b8dec |
قاعدة البيانات: | OpenAIRE |
تدمد: | 10984275 00314005 |
---|